Form 8-K - Current report:
SEC Accession No. 0000950123-99-010963
Filing Date
1999-12-15
Accepted
1999-12-15 00:00:00
Documents
5
Period of Report
1999-11-30
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT 8-K 8862
2 ASSET PURCHASE AGREEMENT EX-2.1 144194
3 AMENDMENT #1 TO ASSET PURCHASE AGREEMENT EX-2.2 4687
4 UNAUDITED PRO FORMA EX-99.1 14034
5 PRESS RELEASE EX-99.2 4810
  Complete submission text file 0000950123-99-010963.txt   178559
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 99775152
SIC: 2835 In Vitro & In Vivo Diagnostic Substances